Although an oral GHSR1a inverse agonist, PF-5190457, reduced alcohol craving in adults with alcohol use disorder with no effect on glucose metabolism, it has not been examined in normal weight or obesity, and effects on appetite and food intake have not been reported [76‐78]. This evidence concerns the gene GHSR and obesity due to melanocortin 4 receptor deficiency.